"De dienst Geneesmiddelenonderzoek van het UZ Gent voert klinisch geneesmiddelenonderzoek (fase 0, I en II) uit en draagt zo bij tot de ontwikkeling van nieuwe en betere geneesmiddelen voor mensen. Het geneesmiddelenonderzoek gebeurt conform de geldende wet- en regelgeving en volgens de hoogste kwaliteitsstandaarden."

During the past decade, Drug Research Unit Gent conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drug Research Unit Gent" #1 sponsor was "International Partnership for Microbicides, Inc." with 2 trials, followed by "Diakron Pharmaceuticals" with 1 trials sponsored, "Khondrion BV" with 1 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "University Hospital, Ghent" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drug Research Unit Gent" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Drug Research Unit Ghent, Belgium" with 1 trials as a collaborator, "Drug Research Unit Ghent, Ghent, Belgium" with 1 trials as a collaborator, "Kinesis Pharma B.V." with 1 trials as a collaborator and "Tibotec Pharmaceutical Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Drug Research Unit Gent" are "HIV Infections" (2 trials), "Deep Vein Thrombosis Leg" (1 trials), "Epilepsy and Neuropathic Pain" (1 trials), "Healthy" (1 trials) and "LHON" (1 trials). Many other conditions were trialed in "Drug Research Unit Gent" in a lesser frequency.

Most popular intervention types in "Drug Research Unit Gent" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "DPOC-4088" (1 trials), "Gabasandoz® (gabapentin) batch A" (1 trials), "Gabasandoz® (gabapentin) batch B" (1 trials) and "KH176" (1 trials). Other intervention names were less common.

The vast majority of trials in "Drug Research Unit Gent" are 2 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Drug Research Unit Gent". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Drug Research Unit Gent, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Drug Research Unit Gent, 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".